Robert W Duggan - Net Worth and Insider Trading
Robert W Duggan Net Worth
The estimated net worth of Robert W Duggan is at least $2.2 Billion dollars as of 2024-04-19. Robert W Duggan is the CEO of Summit Therapeutics Inc and owns about 552,354,161 shares of Summit Therapeutics Inc (SMMT) stock worth over $1.9 Billion. Robert W Duggan is the Director, 10% Owner of Pulse Biosciences Inc and owns about 37,827,813 shares of Pulse Biosciences Inc (PLSE) stock worth over $275 Million. Robert W Duggan is also the 10% Owner of Achaogen Inc and owns about 5,757,839 shares of Achaogen Inc (AKAOQ) stock worth over $143,946. Besides these, Robert W Duggan also holds Intuitive Surgical Inc (ISRG) . Details can be seen in Robert W Duggan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert W Duggan has not made any transactions after 2023-12-12 and currently still holds the listed stock(s).
Transaction Summary of Robert W Duggan
Robert W Duggan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert W Duggan owns 4 companies in total, including Summit Therapeutics Inc () , Pulse Biosciences Inc () , and Achaogen Inc () among others .
Click here to see the complete history of Robert W Duggan’s form 4 insider trades.
Insider Ownership Summary of Robert W Duggan
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Summit Therapeutics Inc | 2023-03-06 | director & 10 percent owner & See Remarks | |
Pulse Biosciences Inc | 2023-12-12 | director & 10 percent owner | |
Achaogen Inc | 2019-03-20 | 10 percent owner | |
Intuitive Surgical Inc | 2011-05-03 | director |
Robert W Duggan Latest Holdings Summary
Robert W Duggan currently owns a total of 4 stocks. Among these stocks, Robert W Duggan owns 552,354,161 shares of Summit Therapeutics Inc (SMMT) as of March 6, 2023, with a value of $1.9 Billion and a weighting of 87.48%. Robert W Duggan owns 37,827,813 shares of Pulse Biosciences Inc (PLSE) as of December 12, 2023, with a value of $275 Million and a weighting of 12.51%. Robert W Duggan also owns 5,757,839 shares of Achaogen Inc (AKAOQ) as of March 20, 2019, with a value of $143,946 and a weighting of 0.01%. The other 1 stocks Intuitive Surgical Inc (ISRG) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Robert W Duggan
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SMMT | Summit Therapeutics Inc | 2023-03-06 | 552,354,161 | 3.48 | 1,922,192,480 |
PLSE | Pulse Biosciences Inc | 2023-12-12 | 37,827,813 | 7.27 | 274,834,193 |
AKAOQ | Achaogen Inc | 2019-03-20 | 5,757,839 | 0.03 | 143,946 |
ISRG | Intuitive Surgical Inc | 2011-05-03 | 0 | 375.00 | 0 |
Holding Weightings of Robert W Duggan
Robert W Duggan Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert W Duggan has made a total of 3 transactions in Summit Therapeutics Inc (SMMT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Summit Therapeutics Inc is the acquisition of 376,489,880 shares on March 6, 2023, which cost Robert W Duggan around $395 Million.
According to the SEC Form 4 filings, Robert W Duggan has made a total of 13 transactions in Pulse Biosciences Inc (PLSE) over the past 5 years, including 13 buys and 0 sells. The most-recent trade in Pulse Biosciences Inc is the acquisition of 17,999 shares on December 12, 2023, which cost Robert W Duggan around $164,691.
According to the SEC Form 4 filings, Robert W Duggan has made a total of 0 transactions in Achaogen Inc (AKAOQ) over the past 5 years. The most-recent trade in Achaogen Inc is the sale of 1,277,888 shares on March 20, 2019, which brought Robert W Duggan around $690,060.
More details on Robert W Duggan's insider transactions can be found in the Insider Trading History of Robert W Duggan table.Insider Trading History of Robert W Duggan
- 1
Robert W Duggan Trading Performance
GuruFocus tracks the stock performance after each of Robert W Duggan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert W Duggan is 6.83%. GuruFocus also compares Robert W Duggan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert W Duggan within 3 months outperforms 23 times out of 47 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert W Duggan's insider trading performs compared to the benchmark.
Performance of Robert W Duggan
Average Return
-43.3%
Outperforming Transactions
12%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 11.67 | 6.83 | -24.16 | -43.3 | -57.44 | -48.05 |
Relative Return to S&P 500(%) | 10.76 | 1.01 | -30.68 | -54.18 | -65.06 | -58.85 |
Robert W Duggan Ownership Network
Ownership Network List of Robert W Duggan
Ownership Network Relation of Robert W Duggan
Robert W Duggan Owned Company Details
What does Summit Therapeutics Inc do?
Who are the key executives at Summit Therapeutics Inc?
Robert W Duggan is the director & 10 percent owner & See Remarks of Summit Therapeutics Inc. Other key executives at Summit Therapeutics Inc include Chief Financial Officer Ankur Dhingra , VP & Corporate Controller Jeffrey R Maranian , and Chief Scientific Officer David Jonathan Powell .
Summit Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Robert W Duggan made 1 insider transaction in Summit Therapeutics Inc () with a net purchase of 376,489,880. Other recent insider transactions involving Summit Therapeutics Inc () include a net purchase of 47,169,409 shares made by Maky Zanganeh , a net purchase of 316,762 shares made by Ankur Dhingra , and a net purchase of 2,976,190 shares made by Manmeet Singh Soni .
In summary, during the past 3 months, insiders sold 0 shares of Summit Therapeutics Inc () in total and bought 210,321 shares, with a net purchase of 210,321 shares. During the past 18 months, 0 shares of Summit Therapeutics Inc () were sold and 426,952,241 shares were bought by its insiders, resulting in a net purchase of 426,952,241 shares.
Summit Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Summit Therapeutics Inc Insider Transactions
Robert W Duggan Mailing Address
Above is the net worth, insider trading, and ownership report for Robert W Duggan. You might contact Robert W Duggan via mailing address: 611 South Fort Harrison Ave, Suite 306, Clearwater Fl 33756.